MS and related disorders: Looking for markers of phenotypes

The Lancet Neurology

Volumn 14, Issue 1, 2015, Pages 11-13

  Trojano, Maria ^a   Tortorella, Carla ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CLASSIFICATION; GENETICS; HUMAN; IMMUNOLOGY; MULTIPLE SCLEROSIS; PHENOTYPE;

BIOLOGICAL MARKERS; HUMANS; MULTIPLE SCLEROSIS; PHENOTYPE;

EID: 84918540931     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70291-1     Document Type: Note

References (9)

1. Wolinsky JS, Narayana PA, O'Connor P, et al. Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial. Ann Neurol 2007, 61:14-24.
2. Hawker K, O'Connor P, Freedman MS, et al. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol 2009, 66:460-471.
3. Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: the 2013 revision. Neurology 2014, 83:278-286.
4. Villar LM, Casanova B, Ouamara N, et al. Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis. Ann Neurol 2014, 76:231-240.
5. Tur C, Ramagopalan S, Altmann DR, et al. HLA-DRB1*15 influences the development of brain tissue damage in early PPMS. Neurology 2014, 83:1712-1718.
6. Du S, Itoha N, Askarinam S, Hill H, Arnold AP, Voskuhl RR XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2014, 18:2806-2811.
7. Kitley J, Woodhall M, Waters P, et al. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 2012, 79:1273-1277.
8. Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014, 82:474-481.
9. Kezuka T, Usui Y, Yamakawa N, et al. Relationship between NMO-antibody and anti-MOG antibody in optic neuritis. J Neuroophthalmol 2012, 32:107-110.